Hadassah Accelerator News
8 articles
"חברות ההזנק הירושלמיות הפכו לחלום הציוני שכולנו משוועים אליו"
The Jerusalem Development Authority (JDA), a statutory corporation established in 1988, is leading the citys high-tech sector with the aim of enabling as many startup companies as possible to grow and develop in the city. The JDA is currently in the process of building approximately one million square meters of office space intended for knowledge-intensive employment across the city. One of the projects that exemplify the unique and significant connection between academia and high-tech in Jerusalem is the Givat Ram Sea Employment Park. The park will include three buildings in the first stage, and then the construction of an additional tower.
Expand
מרעיון למוצר רפואי: האקסלרטור של הדסה
The article discusses the partnership between PathKeeper Surgical and Olive Diagnostics with IBM Alpha Zone. PathKeeper Surgical is a company that specializes in precision spine surgery using 3D imaging, AI-based simulation, and advanced navigation that reduces CT radiation. Olive Diagnostics is a company that uses smart technology to extract urine metrics for molecular analysis using optical technology without taking samples. Both startups have gone through the early stages of their life in the accelerator of Hadassah Medical Center and IBM Alpha Zone. Each of them was paired with a content partner who identified the potential. Both startups have made significant progress on the path from vision to product, and upon leaving the accelerator, they continued to collaborate with Hadassah. They recently completed impressive seed rounds.
InvestmentPartners
The Hadassah Accelerator Launches 5 Healthtech Startups! - JLM-BioCity
The fourth round of the Hadassah Accelerator, powered by IBM, was launched to support Health-Tech startups in improving diagnosis and treatment. The initiative has already raised a total of $15 million, with recent funding of $6 million for MDI Health. The event showcased five startups to investors and senior doctors, aiming to provide medical and financial expertise. The startups featured include LittleOne.Care, CardioLync, IntoSleep, Futura Genetics, and Samplfy. LittleOne.Care is an AI wearable platform for babies well-being, while CardioLync focuses on diagnosing and treating chronic diseases. IntoSleep offers an AI-powered sleep solution, Futura Genetics provides personalized tools for life insurers, and Samplfy enables the collection and digital diagnostics of urine samples. The Hadassah Accelerator is a collaborative initiative led by IBM and the Consensus Business Group, in partnership with the Hadassah Medical Center.
InvestmentPartners
Hadassah Hospital bid to foster tech yields breast milk app, other innovations
IBM has partnered with Hadassah Hospital to operate a startup accelerator focused on developing technologies for the global medical market. The accelerator, located in Jerusalem, provides early-stage startups with workspace, access to the hospitals infrastructure and medical staff, and the opportunity to work with IBMs databases and software. The program aims to maximize innovation within the hospital and help startups bring their ideas into the healthcare industry. The first cohort of startups has already graduated, with products ranging from a handheld breast milk scanner to an AI-based surgery navigation system. The second cohort has recently begun, with startups working on technologies such as autonomous identification of treatment gaps and wearable devices for pain reduction.
PartnersExpand
Hadassah and IBM's Jerusalem Medtech Accelerator Graduates First Cohort
Hadassah Accelerator, a joint venture between IBMs Israel accelerator, IBM Alpha Zone, The Jerusalem Development Authority, and Hadassah Medical Center, has graduated its first cohort of medtech startups. The six-month program offers participating companies access to clinical and research resources, free office space, and mentorship. The second cohort has also been selected.
PartnersCustomers
ביוהאוס: מתחם חדשנות בתחום הבריאות
BIOHOUSE Hadassah, a new innovation hub for entrepreneurs in the bio-med field, has been established in Jerusalem. The hub, which was set up by the LR Group and supported by the Jerusalem Development Authority, aims to accelerate medical technology into a new era. The hub, which spans 1,300 square meters and houses around 200 workstations, is designed to accommodate dozens of startups in the fields of digital medicine, medical equipment, and biotechnology. One of the most exciting initiatives in the complex is an accelerator run by the Hadassah Medical Center in partnership with IBM.
PartnersExpand
IBM and Israeli hospital establish digital health accelerator
IBM Israel and Hadassah Medical Center have established an accelerator program for startups to develop digital health tools and solutions. The program, set to begin in the first quarter of 2019, will last for six months and is open to startups that have completed a post-seed round of financing. Participating companies will receive access to resources and medical expertise from Hadassah, while IBM will provide technology advice and access to services like hosting on IBM Cloud. The accelerator will be located in the Biohouse technology incubator at the Hadassah Ein Kerem Medical Center and will be supported by the Jerusalem Development Authority.
PartnersExpand
Hadassah, IBM set up digital health accelerator
Hadassah Medical Center in Jerusalem and IBM Israel have announced the establishment of a special accelerator for startups in digital medicine. The accelerator program will provide companies with access to hospital resources and technological assistance. Startups that have completed a post-seed financing round will be eligible for the program. The accelerator will be built by the LR group on the premises of the Biohouse technology incubator in the Hadassah Ein Kerem Medical Center. IBM will provide technological advice and free access to its advanced technological tools. The program is scheduled to begin in the first quarter of 2019 and will last six months.
PartnersInvestment
